PD-L1-expressing dendritic cells demonstrate therapeutic effects in EAE, but there is still insufficient data for the immune-modulatory functions of PD-1/PD-L1-pathway-related EVs in MS [63]. The gene discussed is PDCD1; the disease is myeloid sarcoma.